Logo for Precision BioSciences Inc

Precision BioSciences Investor Relations Material

Latest events

Logo for Precision BioSciences Inc

Status Update

Precision BioSciences
Logo for Precision BioSciences

Q1 2025

15 May, 2025
Logo for Precision BioSciences

Status Update

15 May, 2025
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies

Latest reports from Precision BioSciences Inc

Access all reports
Precision BioSciences Inc. is a U.S.-based biotechnology company focused on developing gene editing technologies. The company utilizes its proprietary ARCUS genome editing platform to research and develop treatments for genetic disorders and cancers. Its work spans cell and gene therapies, with applications in both in vivo and allogeneic CAR T-cell therapies. Precision BioSciences collaborates with academic institutions and pharmaceutical companies to advance its research and clinical programs. The company is headquartered in Durham, North Carolina, and its shares are listed on the NASDAQ.